User profiles for J.-B. Masson

jean-baptiste Masson

research scientist, Pasteur Institute, Paris, France
Verified email at pasteur.fr
Cited by 3162

Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes

…, A Cheung, J Ye, S Lichtenstein, M Lee, JB Masson… - Circulation, 2009 - Am Heart Assoc
Background— Transcatheter aortic valve implantation is an alternative to open heart surgery
in patients with aortic stenosis. However, long-term data on a programmatic approach to …

Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves

JG Webb, DA Wood, J Ye, R Gurvitch, JB Masson… - Circulation, 2010 - Am Heart Assoc
Background— The majority of prosthetic heart valves currently implanted are tissue valves
that can be expected to degenerate with time and eventually fail. Repeat cardiac surgery to …

Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications

JB Masson, J Kovac, G Schuler, J Ye, A Cheung… - JACC: Cardiovascular …, 2009 - jacc.org
Transcatheter aortic valve implantation (TAVI) is becoming a reality in the management of
patients with severe aortic stenosis and high or prohibitive risk for standard surgical …

Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement

…, R De Larochelliere, D Doyle, JB Masson… - European heart …, 2010 - academic.oup.com
Aims Very few data exist on the occurrence of acute kidney injury (AKI) associated with
transcatheter aortic valve implantation (TAVI). The objectives of the present study were (i) to …

Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis

…, R De Larochellière, D Doyle, JB Masson… - Journal of the American …, 2009 - jacc.org
Objectives : This study was undertaken to compare the hemodynamic performance of a
percutaneous bioprosthesis to that of surgically implanted (stented and stentless) bioprostheses …

Dynamics of CRISPR-Cas9 genome interrogation in living cells

…, L Bosanac, ET Zhang, M El Beheiry, JB Masson… - Science, 2015 - science.org
The RNA-guided CRISPR-associated protein Cas9 is used for genome editing, transcriptional
modulation, and live-cell imaging. Cas9-guide RNA complexes recognize and cleave …

[HTML][HTML] Objective comparison of methods to decode anomalous diffusion

…, H Loch-Olszewska, MA Lomholt, JB Masson… - Nature …, 2021 - nature.com
Deviations from Brownian motion leading to anomalous diffusion are found in transport
dynamics from quantum physics to life sciences. The characterization of anomalous diffusion …

Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification

…, R Rampat, PFG Nicz, JB Masson… - European heart …, 2019 - academic.oup.com
Aims We sought to evaluate the outcomes of transcatheter mitral valve replacement (TMVR)
for patients with degenerated bioprostheses [valve-in-valve (ViV)], failed annuloplasty rings […

Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction

MA Clavel, JG Webb, J Rodés-Cabau, JB Masson… - Circulation, 2010 - Am Heart Assoc
Background— Patients with severe aortic stenosis and reduced left ventricular ejection
fraction (LVEF) have a poor prognosis with conservative therapy but a high operative mortality …

Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve: the ARTE …

J Rodés-Cabau, JB Masson, RC Welsh… - JACC: Cardiovascular …, 2017 - jacc.org
Objectives : The aim of this study was to compare aspirin plus clopidogrel with aspirin alone
as antithrombotic treatment following transcatheter aortic valve replacement (TAVR) for the …